Abstract:Renal cell carcinoma (RCC) is a common malignancy of the urinary system. Although traditional therapies, such as surgery assisted with chemotherapy have improved the quality of life and survival time of patients with RCC, patients with metastasis or recurrence benefit little from such therapies. At present, little is known about the underlying mechanisms of RCC, rendering treatment selection and implementation challenging. Therefore, investigating the cause and underlying mechanisms of RCC remain of importance to explore potential new avenues for its treatment. Inter-alpha-trypsin inhibitor heavy chain 1 (ITIH1) is an inflammation-associated gene reported to suppress the progression of liver cancer. However, its role in RCC remains poorly understood. Therefore, the present study aimed to investigate the role and mechanism of ITIH1 in RCC. Based on data obtained from The Cancer Genome Atlas database, ITIH1 expression was demonstrated to be significantly higher in tumor tissues compared with normal tissues, which was in turn negatively associated with the survival of patients with RCC. However, in RCC cells, ITIH1 was shown to be expressed at significantly lower levels compared with those in HK-2 cells. The discrepancy between tissues and cell lines might be due to the different environment of cell growth. ITIH1 knockdown in RCC cells significantly increased cell proliferation and invasion whilst significantly decreasing the apoptosis rate, compared with those in control cells (without ITIH1 knockdown). By contrast, overexpression of ITIH1 significantly inhibited cell proliferation and invasion in RCC cells. In terms of western blotting results, the phosphorylation levels of NF-kappa B were significantly increased following ITIH1 knockdown. The protein expression level of I kappa B significantly decreased whereas that of IKK, Cyclin D1, proliferating cell nuclear antigen and alpha-smooth muscle actin were significantly increased in ITIH1-knockdown cells, compared with those in the control cells (without ITIH1 knockdown). This suggests that the NF-kappa B pathway may be activated after ITIH1 knockdown. Following treatment with the NF-kappa B pathway inhibitor JSH-23 in combination with ITIH1 knockdown, RCC cell proliferation and invasion were significantly reduced compared with those after ITIH1 knockdown alone. In summary, results from the present study suggest that ITIH1 can serve an inhibitory role in the progression of RCC, which could potentially be inhibited through the NF-kappa B signaling pathway.

Silencing of HIF-1α Suppresses Tumorigenicity of Renal Cell Carcinoma Through Induction of Apoptosis

Inhibition of RIPK 1 expression and facilitation of TRAIL-induced hepatocellular carcinoma cell apoptosis by miR-141

RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells

Silencing HIF-1α Aggravates Growth Inhibition and Necrosis of Proximal Renal Tubular Epithelial Cell under Hypoxia

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

[Effect of Silencing Hypoxia-Inducible Factor-1 Alpha by RNA Interference on Human Breast Carcinoma Cell Line].

Effect of HIF-1αby RNAi on Radiosensitivity in Esophageal Squamous Carcinoma Cell Line Eca109 under Hypoxia

Hypoxia Inducible Factor-1Α Gene Silencing Aggravates Growth Inhibition and Necrosis of Human Proximal Renal Tubular Epithelial Cell under Hypoxia

HIF2 inactivation and tumor suppression with a tumor-directed RNA-silencing drug in mice and humans

hZIP1 Inhibits Progression of Clear Cell Renal Cell Carcinoma by Suppressing NF-kB/HIF-1α Pathway

Hypoxia inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion

ITIH1 Suppresses Carcinogenesis in Renal Cell Carcinoma Through Regulation of the NF‑κB Signaling Pathway

Long Non-Coding RNA HIF1A-AS2 Promotes Carcinogenesis by Enhancing Gli1-mediated HIF1α Expression in Clear Cell Renal Cell Carcinoma.

Inhibition of Tumor Growth and Sensitization to Sunitinib by RNA Interference Targeting Programmed Death-ligand 1 in Mouse Renal Cell Carcinoma RenCa Model

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress

The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis

Inhibition of hypoxia inducible factor 1α expression suppresses the progression of esophageal squamous cell carcinoma.

Hypoxia-inducible factor 1α (HIF-1α) correlated with tumor growth and apoptosis in ovarian cancer

Expression and significance of HIF-1α mRNA and HIF-2α mRNA in human renal clear cell cancer

Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells

HIF-1 α shRNAs delivered by ultrasound-targeted cationic microbubble inhibit proliferation , migration , and invasion of ovarian cancer cells